Our study highlights a role of asparagine in regulating RIG-I stability and connects asparagine metabolism to the IFN-I signaling that modulates antitumor immunity, suggesting that targeting ASNS is a promising approach to enhance immunotherapy for bladder cancer. This evidence concerns the gene RIGI and urinary bladder cancer.